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Hypothermic synchronized retroperfusion was applied
during coronary artery occlusion to determine its ability
to alleviate junctional derangements of reperfusion and
to reduce infarct size. The proximal left anterior de-
scending coronary artery was occluded in 25 closedchest
dogs for 3 hours and then reperfused for 7 days. Thirteen
dogs with no reperfusion pretreatment served as a con-
trol group (Group A). In 12 dogs, hypothermic retro-
perfusion was applied from 30 minutes up to 3 hours of
the occlusion period (Group B). Sequential two-dimen-
sional echocardiographic and hemodynamic as well as
metabolicmeasurements were performed. Compared with
untreated control dogs, dogs with hypothermic syn-
chronized retroperfusion had significantly reduced heart
rate and rate-pressure product, decreased left ventric-
ular volumes and improved ejection fraction during the
occlusion period. Two-dimensional echocardiographi-
cally-derivedischemic zone systolic fractional area change
and systolic wall thickening indicated significantly im-
Reperfusion after acute coronary occlusion is often asso-
ciated with a "no reflow" phenomenon (1) that may cause
at least temporary and occasionally extended derangements
in cardiac function (2). Numerous treatments have been
proposed to minimize the postreperfusion syndrome, con-
sisting of ventricular dysfunction, arrhythmias, cellular and
interstitial edema and hemorrhage. Experimental studies (3-
8) indicated that several pharmacologic agents or intraaortic
balloon pumping used before and during reperfusion might
prove beneficial by minimizing the no reflow phenomenon
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proved function as a result of retroperfusion. During the
reperfusion period, untreated control dogs (group A)
had more severe derangements in hemodynamics and
wall motion than dogs treated by hypothermic retro-
perfusion (group B). Mortality was 30.7% in group A,
16.7% in group B and 7th day infarct size as percent of
the left ventricle was 12.0 ± 6.5 (mean ± standard
deviation) and 4.2 ± 5.9, respectively (p < 0.02).
It is concluded that hypothermic synchronized retro-
perfusion applied after coronary occlusion and before
reperfusion significantly improves cardiac function dur-
ing occlusion, minimizes complications of reperfusion
and reduces the ultimate infarct size. Because this form
of circulatory assistance helps maintain cardiac function
and delays the evolution of myocardial necrosis, its ap-
plication may be beneficial during an evolving acute
myocardial infarction before achievement of surgical or
nonsurgical reperfusion,
and improving the myocardial oxygen supply to demand
ratio. As yet, there has been no evaluation of hypothermic
retroperfusion, which enhances coronary blood flow through
coronary veins, increasing perfusion and function of acutely
ischemic myocardium and extending its viability(9-11).
A surgical mode of retroperfusion was described in 1948
by Beck et al. (12), who reported significant improvement
in cardiac function and decreased mortality. Subsequent
long-term follow-up studies (13) of this method showed less
satisfactory cardiac function and unacceptable mortality in
patients with coronary artery disease, attributed in part to
damage resulting from obstruction of the coronary venous
drainage. Nonsurgical retroperfusion for treatment of acutely
ischemic myocardium was emphasized by several investi-
gators (14-17) in the early 1970s. Significant progress was
achieved in 1976 when Meerbaum et al. (18) introduced a
synchronized phased diastolic retroperfusion that features
coronary venous drainage during systole. The combination
of synchronized retroperfusion with moderate cooling fur-
ther enhanced the treatment of myocardial ischemia (II).
The proposed clinical application of this method is as a
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Figure 1. Two-dimensional echocardiographic short-axis cross-sectional
view at the level of the high papillary muscles. The left ventricular (LV)
cavitywithendocardial andepicardial outlines is wellseen. Alsoindicated
are the anterior(small arrow) and posterior (big arrow) junctions of the
left and right (RV) ventricles.
Figure 2. Computer-assisted outlines of epicardial and endocardial sur-
faces at end-diastole (continuous lines) and end-systole (dashed lines)
derived froma short-axis echocardiogram at thehighpapillary muscle level
in control state. The cross sections were subdivided into 8 equally spaced
segments using standardized indexing and fixed internal referencing. The
indexing line wasderivedconnecting the anterior junctionof the rightand
left ventricles (indicated by an x) to the endocardial geometric center at
end-diastole. The computer automatically calculates areas and perimeters
for the total section as well as for each of the left ventricular segments.
into 8 segments, using a standardized fixed axis with internal
referencing system (Fig. 2). The basic indexing line used in sub-
dividing the short-axis sections was constructed by connecting the
anterior junction of the right and left ventricle (indicated in Frg.I)
to the section's endocardial geometric center in end-diastole. A
computer-aided system was used to calculate areas, perimeters,
wall thickness and derived indexes of function for the overall short-
axis sections as well as for each of the segments within the sections.
Metabolic measurements. Arterial samples were obtained at
regular intervals for analysis of blood gases (partial pressure of
oxygen, partial pressure of carbon dioxide) and pH. Lactate levels
were determined in blood samples from the aortic root and the
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temporary support in acute ischemia until more definitive
surgical or nonsurgical reperfusion can be instituted to save
the jeopardized zone. In this report, we examine whether
treatment of acutely ischemic myocardium by moderately
hypothermic synchronized retroperfusion of the coronary
veins provides significant functional benefits during the early
phase of reperfusion and reduces the ultimate infarct size.
Experimental preparation. Forty-one healthy mongrel dogs,
weighing 22 to 35 kg, were anesthetized with sodium pentobarbital
(30 mg/kg intravenously) 20 minutes after premedication with
intramuscular morphine (1.2 rng/kg). Heparin (10,000 IV intra-
venously) was given before instrumentation, and supplemented
with 3,000 IV every 2 hours. Pentobarbital (3 mg/kg intravenously)
was supplemented when necessary.
In an aseptic preparation, a 2 French Fogarty arterial embo-
lectomy catheter was introduced in the closed chest under fluo-
roscopic control by way of the left carotid artery. After coronary
angiography, the catheter balloon was positioned immediately above
the first diagonal branch of the left anterior descending coronary
artery. Aortic and left ventricular catheters were introduced through
the femoral arteries and connected to Statham P23Db transducers
for measurements of aortic root and left ventricular pressures. The
first derivative of left ventricular pressure (dP/dt) was derived
directly from the left ventricular pressure by electrical differentia-
tion, and left ventricular end-diastolic pressure was magnified by
a factor of 4. All pressures and the electrocardiogram were mon-
itored on an Electronics for Medicine recorder V-12. A Swan-
Ganz 7 French thermodilution catheter was placed in the pulmonary
artery for cardiac output measurement (American Edwards
Laboratories) .
Two-dimensional echocardiographic measurements. Two-
dimensional echocardiography (Advanced Technology Laborato-
ries) was used for sequential measurements of global and regional
left ventricular function. A parasternal long-axis view and several
left ventricular short-axis cross sections (Fig. 1) were obtained in
all dogs, and left ventricular volumes as well as ejection fraction
were reconstructed using a modified Simpson's rule, as previously
described (19). Intraluminal systolic fractional area of change,
averaged end-diastolic wall thickness and systolic wall thickening
were calculated for each cross section at several levels (mitral
valve; high, mid and low papillary muscle; low left ventricle) as
follows:
where EDA = end-diastolic area, ESA = end-systolic area and
FAC = systolic fractional area change; and
WTs - WTd
WT(%) = WTd x 100,
where WTs = wall thickness at end-systole, WId = wall thick-
ness at end-diastole and WT = systolic wall thickening.
For more detailed left ventricular mapping, segmental frac-
tional area change, diastolic wall thickness and systolic wall thick-
ening were also calculated after subdividing each cross section
FAC(%)
EDA - ESA
EDA x 100,
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Figure 4. Operationof the retroperfusion autoinflatable balloon catheter.
A, During ventriculardiastole the balloon is inflated while arterial blood
is propelledtoward the ischemiczone. B, In systole retroperfusion stops,
the balloon promptlycollapsesand regional coronary vems drain mto the
great cardiac vein (GCV) and around the retroperfusion catheter into the
coronary sinus (CS) and right atrium.
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drawn from the ice water, allowing the retroinfusate temperature
at the pump to increase to between 26 and 28°C. This gradual
rewarming was provided to avoid myocardial temperature gra-
dients and consequent potential arrhythmias (20). Rectal temper-
atures were monitored in the dogs throughout the experiment.
Experimental protocol. In all dogs, the proximal left anterior
descending coronary artery was occluded for 3 hours, and then
reperfused by deflating the intracoronary occluding balloon and
withdrawing the 2 French balloon catheter. The control group
(group A) had no treatment between 0 and 3 hours of the coronary
occlusion. while in the treated group (group B) hypothermic re-
troperfusion was used from 30 minutes after occlusion, either up
to the end of the 3 hour occlusion period (group B-1), or else up
to I hour after reperfusion (group B-2). Sequential hemodynamic,
two-dimensional echographic and metabolic measurements were
obtained in all dogs during the control state, at 30, 90 and 180
minutes after the coronary occlusion and during the early phase
of reflow, that is, at 15, 30 and 60 minutes after reperfusion. The
dogs with reperfusion were then given antibiotic drugs (penicillin G
I million U, intramuscularly plus streptomycin 0.5 g intramus-
cularly, daily) and maintained in the vivarium under controlled
conditions.
Echocardiograms wereperformedin the conscious dogs24 and
72 hours after the reperfusion. On the 7th day, all measurements
were repeated after anesthesia and complete instrumentation of the
dogs. No attempt was made to defibrillate any of the dogs during
the occlusion or reperfusion periods; however, lidocaine was given
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Figure 3. Schematic of experimental synchronized retroperfusion system.
Arterial blood is shunted from the brachial artery into the great cardiac
vein. The blood is pumped by means of an electrocardiographically syn-
chronizedbladderpumpactuatedby a standardcounterpulsation unit. Flow
rate is monitored with an electromagnetic (EM) flowmeter. The cooling
coil for moderately hypothermic retroperfusion is also shown. The left
anterior descending (LAD) coronary artery is occluded by means of an
intracoronary ballooncatheter, resulting in regional acute ischemia. AI =
anterior interventricular; SRP = synchronized retroperfusion.
great cardiac vein. The coronary venous samples for lactate mea-
surements were obtained through the center lumen of the great
cardiac vein catheter after stopping the retroperfusion pumping for
2 minutes to allow complete venous drainage. Myocardial lactate
balance was calculated as the arteriovenous difference divided by
the arterial value.
Hypothermic synchronized retroperfusion system. The syn-
chronized retroperfusion system developed in our laboratory (18)
was adapted for hypothermic retroperfusion (Fig. 3). Briefly, ar-
terial blood was shunted from the aortic arch (through an 8 French
catheter introduced by way of the brachial artery) into the great
cardiac vein. The arterial blood was propelled by means of a gas-
actuated pulsatile bladder pump controlled with a synchronized
intraaortic balloon system (AVCO Medical Products). The pump
was adjusted to provide diastolic retrograde flow of arterial blood
toward the ischemic zone, while stopping forward flow which
facilitated coronary venous drainage during systole. The single
lumen autoinflatable retroperfusion balloon catheter and its oper-
ation are illustrated in Figure 4. The balloon is rapidly inflated
during diastole (Fig. 4A) and deflates promptly in systole (Fig.
4B) allowing drainage around the collapsed catheter into the coro-
nary sinus and right atrium. The system was regulated to operate
at a mean retroinfusion flow rate of 40 to 60 cc/rnin, measured
with an electromagnetic flowmeter. There ranges of flow have
been previously reported to be associated with anterior interven-
tricular vein blood pressures not exceeding 50 mm Hg, therefore
avoiding vascular damage (18). On the basis of prior experience,
a moderate degree of myocardial hypothermia was induced by
externally cooling the arterial blood to a temperature of 16°C at
the extracorporeal pump. This was achieved by immersing a looped
cannula into ice water (Fig. 3). Approximately 10 minutes before
anterograde coronary reperfusion was instituted through intra-
coronary balloon deflation, the retroperfusion cannula was with-
1070 J AM cou. CARDIOl
1983;1(4) 1067-80
HAENDCHEN ET Al
whenever ventricular tachycardia or frequent ventricular premature
complexes were encountered (40 mg intravenous bolus, and 2 mg/
min subsequently). Heparin 00,000 IU, subcutaneously) was given
at 60 minutes after reperfusion and subsequently every 24 hours.
Pathologic study. At the end of the 7th day of restudy, the
dogs were sacrificed. After gross macroscopic inspection, all hearts
were sliced into 8 to 10 mm thick transverse slabs parallel to the
atrioventricular groove, and stained with triphenyl-tetrazolium-
chloride for determination of infarct size (21). The stained slabs
were fixed in formalin and photographed, and the infarcted area
was quantitated by planimetry. After removal of the atria, right
ventricle, pulmonary artery, aorta and pericardium, percent left
ventricular necrosis was calculated using the weight of the left
ventricle and interventricular septum. Gross inspection and mi-
croscopic examination of the coronary sinus and coronary veins
were performed in all dogs in group B to detect potential long-
term damage that might be induced in the coronary venous cir-
culation during retroperfusion.
Statistical analysis. The effects of coronary artery occlusion
and reperfusion on hemodynamic variables, two-dimensional
echocardiographic measurements, myocardial metabolism and in-
farct size were compared in the groups using Student's t test for
unpaired data. Unless otherwise indicated, data are expressed as
mean values ± standard deviation.
Results
There were no significant differences between dogs in
group B-1 (n = 5) or B-2 (n = 5) in any of the physiologic
measurements studied, so that all dogs with retroperfusion
were considered a single series (group B whether the retro-
perfusion was maintained up to or for 1 hour beyond
reperfusion).
Survival. Of the 4I dogs that entered the study, 9 (22.0%)
died between 0 and 30 minutes of coronary occlusion before
assignment to any group, and were excluded from the study.
All these dogs died of ventricular fibrillation, except for one
in which a decreased blood pressure led to cardiogenic shock
and death. Also excluded from the analyses were seven
(17. 1%) other dogs that were considered to be free of isch-
emia and exhibited neither changes in electrocardiogram
nor any significant regional wall motion abnormalities
throughout the initial 30 minutes of coronary occlusion. Of
the remaining 25 dogs, all of which exhibited significant
wall motion abnormalities as well as ST segment elevation
after coronary occlusion, 13 were assigned to group A (un-
treated) and 12 to group B (treated with retroperfusion). Six
(24.0%) of these dogs died either between 12 and 24 hours
after anterograde reperfusion (two dogs in each group) or
between 24 hours and 7 days after reperfusion (two dogs
from group A). None of the dogs in group B died between
24 hours and 7 days after reperfusion. Nineteen dogs sur-
vived 7 days, 9 from group A and 10 from group B.
Hemodynamics (Table 1). There were no significant
differences between groups A and B in aortic pressure, heart
rate, cardiac index, left ventricular end-diastolic pressure,
first derivative of left ventricular pressure (dP/dt) or systemic
vascular resistance during the preocclusion control period
or at 30 minutes after occlusion. Thereafter, dogs in group
B were treated with hypothermic retroperfusion. At 90 min-
utes after occlusion, left ventricular end-diastolic pressure
was significantly lower in group B, and at 180 minutes, the
rate-pressure product (mean aortic pressure X mean heart
rate) was also significantly lower in group B. During the
early phase of the anterograde coronary reperfusion (15 and
60 minutes), heart rate and rate-pressure product were again
significantly lower in group B.
Although the majority of dogs had some degree of hemo-
dynamic derangement during early reperfusion, dogs in group
A exhibited a more dramatic deterioration between 180 min-
utes of coronary occlusion and 60 minutes after reperfusion.
For instance, left ventricular stroke work index decreased
only 13.5 ± 7.9% in group B as compared with 37.5 ±
15.1% reduction in group A. On the 7th day, left ventricular
dP/dt was significantly higher in group B than in group A.
Two-dimensional echocardiographic data. Left ven-
tricular volumes and ejection fraction (Table 2). As a result
of acute myocardial ischemia, dogs in both groups exhibited
increased left ventricular volumes and decreased ejection
fraction during the 30 minute coronary occlusion. Hypo-
thermic retroperfusion applied after 30 minutes of occlusion
in group B resulted in significantly decreased left ventricular
volumes and improved ejection fraction, whereas in dogs
from group A end-diastolic volume decreased only slightly,
end-systolic volume remained significantly elevated and a
lower ejection fraction persisted over the entire 3 hour period
of coronary occlusion. Subsequently, during the early stage
of reperfusion, the untreated dogs exhibited further deteri-
oration in ejection fraction. In group B, left ventricular
volumes increased slightly and there was a small drop in
ejection fraction early after reperfusion. At 24 hours after
reperfusion, left ventricular volumes were markedly de-
creased in both groups of dogs. However, ejection fraction
remained depressed in group A at 72 hours and even 7 days
after reperfusion, while returning to nearly control values
in group B as early as 24 hours after reperfusion.
Global and segmental wall motion assessed byfractional
area change (Table 3). At 30 minutes after coronary oc-
clusion, two-dimensional echocardiographic measurements
in both groups of dogs indicated minor changes in the global
sectional systolic fractional area change at the level of the
mitral valve, which was above the site of the coronary
occlusion. However, a marked decrease in sectional con-
traction was observed at the level of the midpapillary mus-
cles and at lower levels of the left ventricle. Reperfusion
after 3 hours of untreated coronary occlusion (group A)
resulted in a further deterioration in sectional fractional area
change measured at both midpapillary and low left ventric-
ular levels, and also caused a depressed contraction at the
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Table 1. Hemodynamic Data
Control
Time After Coronary Occlusion Time After Coronary Reperfusion
(preocclusion) 30 nun 90 mill 180 min 15 min 60 min 7 days
Heart rate (beats/min)
Group A 78 ± 17 92 ± 19 88 ± 25 99 ± 22 106 ± 15 112 ± 26 123 ± 23
Group B 75 ± 19 84 ± 21 96 ± 27 81 ± 24 *87 ± 19 *85 ± 20 105 ± 24
Mean aortic pressure (mm
Hg)
Group A 97 ± 7 97 ± 8 97 ± 14 115 ± 15 119 ± 19 118 ± 19 99 ± 17
Group B 102 ± 9 98 ± 9 101 ± 9 107 ± II III ± 13 III ± 9 105 ± 16
LVEDP (mm Hg)
Group A 40 ± 3 11.0 ± 5 70 ± 4 6.0 ± 6 100 ± 6 12.0 ± 8 2.0 ± 15
Group B 3.0 ± I 8.0 ± 4 *2.0 ± 2 4.0 ± 3 70 ± 5 90 ± 6 4.0 ± 2.2
Systemic vascular resistance
(dynes-s-cm" x 103)
Group A 2.6 ± 0.5 2.7 ± 0.7 2.5 ± 0.4 3.6 ± 0.8 4.1 ± 0.8 44 ± 09 3.3 ± 1.4
Group B 2.9 ± 1.I 3.0 ± 1.3 2.7 ± 1.0 36 ± I I 4.1 ± 1.6 4.4 ± 1.7 2.3 ± 06
LV dP/dt (mm Hg/s)
Group A 1784 ± 250 1487 ± 234 1510 ± 378 1584 ± 332 1323 ± 288 1307 ± 272 1569 ± 338
Group B 2092 ± 479 1737 ± 314 2140 ± 533 1856 ± 524 1556 ± 496 1513 ± 497 *2183 ± 416
LV stroke work Index
(g/beat per nr')
Group A 46 ± 8 36 ± 5 43 ± 14 40 ± 15 31 ± 7 28 ± 7 30 ± 15
Group B 50 ± II 36 ± 6 38 ± 8 38 ± 10 34 ± 12 33 ± 14 42 ± 8
Double product (heart rate
x mean aortic
pressure x 103)
Group A 7.6 ± 1.8 88±1.5 8.5 ± 2.8 112±2.4 12.6 ± 24 13.0 ± 30 124 ± 40
Group B 7.7 ± 2.3 8.2 ± 2.3 97 ± 3.1 *8.5 ± 20 *9.4 ± 1.0 *9.2 ± I 9 11.5 ± 4.0
*p < 0 05 relative 10 group A
Values are mean:+: standard deviatron LVEDP = leftventncular end-drastohc pressure, LV dP/dt = maximal rate of me of lett ventricular prevsure
mitral valve level. This functional deterioration in dogs from
group A was in sharp contrast to dogs from group B in
which fractional area change improved with hypothermic
retroperfusion, and derangements during the first hour after
reperfusion appeared minor. More detailed study of specific
ischemic segments at the level of the papillary muscles
indicated markedly depressed segmental fractional area change
in dogs from group A. This dysfunction in untreated dogs
persisted throughout the 3 hour period of coronary occlu-
sion, deteriorated further during early reperfusion and did
not return to normal after 7 days of reperfusion. Incontrast,
most of the dogs in group B exhibited significant improve-
ments in ischemic segment fractional area change during
the coronary occlusion and reperfusion.
Systolic wall thickening (Table 4). In both groups of
dogs. systolic wall thickening in the ischemic region was
Table 2. Two-Dimensional Echocardiographic Left Ventricular Volumes and Ejection Fraction
Control
Time After Coronary OcclUSIOn Time After Coronary Reperfusion
(prcocclusion) 30 min 90 min 180 mill 15 mill 60 mill 24 hr 72 hr 7 days
LVEDVI
Group A 76 ± 12 107 ± 22 99 ± 18 88 ± 16 81 ± 24 84 ± 16 62 ± 15 79 ± 14 77 ± 7
Group B 82 ± 21 108 ± 22 87 ± 22 91 ± 33 95 ± 34 101 ± 30 67 ± 14 95 ± 24 83 ± 13
LVESVI
Group A 31 ± 6 69 ± 19 62 ± 10 57 ± II 55 ± 17 58 ± 13 37 ± II 44 ± 9 43 ± 8
Group B 34 ± II 70 ± 16 *43 ± II 48 ± 21 55 ± 23 59 ± 22 31 ± 8 41 ± 9 38 ± 8
LVEF
Group A 60 ± 4 36 ± 7 37 ± 5 35 ± 5 32 ± 4 31 ± 5 41 ± 6 44 ± 6 43 ± 7
Group B 59 ± 4 35 ± 7 t50 ± 5 t49 ± 6 t44 ± 7 t43 ± 9 *54 ± 8 *54 ± 8 t55 ± 5
*p < 0 05 relative to group A, tp < 0 00I relative 10 group A
Values are mean:+: standard deviation LVEDVI = leftventricular end-diastohc volume Index (ml/rn"), LVEF ~ left ventricular ejection fraction (o/c). LVESVI = left
ventricular end-systolic volume Index (ml/nr')
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Table 3. Two-Dimensional Echocardiographic Systolic Fractional Area Change in Left Ventricular Short-Axis Cross Sections
Control
Time After Coronary Occlusion Time After Coronary Reperfusion
(preocclusron) 30 min 90 min 180 min 15 min 60 min 24 hr 72 hr 7 days
MV level
Group A 38 ± 3 33 ± 5 37 ± 5 38 ± 6 30 ± 5 29 ± 3 34 ± 4 36 ± 4 35 ± 5
Group B 39 ± 4 36 ± 6 t46 ± 6 *44 ± 3 *36 ± 4 t37 ± 3 *42 ± 8 *44 ± 6 *45 ± 5
MP level
Group A 54 ± 3 27 ± 7 29 ± 4 27 ± 6 27 ± 5 26 ± 8 37 ± II 40 ± 8 39 ± II
Group B 54 ± 4 31 ± 6 t45 ± 9 t44 ± 12 t41 ± 9 *40 ± 10 t51 ± II *51 ± 9 49 ± 4
LLV level
Group A 58 ± 6 20 ± 6 23 ± 4 21 ± 4 20 ± 7 19 ± 5 29 ± II 30 ± 6 33 ± 7
Group B 55 ± 5 20 ± 6 *34 ± 8 *33 ± 9 *30 ± 10 *31 ± 16 *45 ± 14 *43 ± 12 *46 ± 13
MP level-I zone
Group A 53 ± 6 I ± 8 I ± 7 -I ± 12 -4 ± 7 -8 ± 7 6 ± 21 18 ± 23 II ± 20
Group B 56 ± 12 3 ± II t33 ± 19 *25 ± 22 t26 ± 17 t24 ± 22 *38 ± 26 37 ± 20 *40 ± 17
MP level-NI zone
Group A 65 ± 8 52 ± II 51 ± II 58 ± 16 56 ± 13 61 ± 19 62 ± 13 66 ± 6 67 ± 9
Group B 62 ± II 48 ± 12 59 ± 9 59 ± 8 55 ± 12 52 ± 14 62 ± 9 63 ± 10 62 ± 8
*p < 0 05 relative to group A; tp < 0.001 relative to group A
Values are mean ± standard deviallon. I = rschermc, LLV = low left ventncular. MP = rmdpaprllary, MV = rmtral valve; NI = nomschermc
found to be severely depressed at 30 minutes after occlusion.
In group A, this dysfunction persisted throughout the 3 hour
coronary occlusion as well as the 7 day period of reperfu-
sion. In contrast, the majority of dogs in group B showed
an increase in systolic wall thickening in the ischemic region
when the retroperfusion treatment was initiated. Further-
more, compared with dogs in group A, dogs in group B
also presented a better functional response after reperfusion
in terms of segmental systolic wall thickening (Fig. 5).
End-diastolic wall thickness (Table 5). The end-diastolic
wall thickness in the ischemic region was markedly in-
creased with reperfusion in most of the untreated dogs,
especially in the first 60 minutes after reperfusion. In striking
contrast, only 2 of the 10 dogs treated with hypothermic
retroperfusion showed any evidence of increased diastolic
wall thickness in the first 60 minutes after reperfusion. Fur-
thermore, the marked increase in ischemic region diastolic
wall thickness persisted in group A up to 72 hours after the
reperfusion, and in some instances was present even after
7 days ofreperfusion. At the low left ventricular level, group
A dogs exhibited a significant increase in sectional diastolic
wall thickness after reperfusion as compared with group B.
Diastolic wall thickness in the ischemic region at the mid-
papillary muscle level decreased by approximately 15% in
both groups at 30 minutes of coronary occlusion, but in-
creased by 56.5 ± 26.0% from 180 minutes of occlusion
to 15 minutes after reperfusion in group A, as opposed to
an increase of only 12.4 ± 27.2% in group B (p < 0.01).
Figure 6 illustrates this increase in one dog from group A.
The percent changes in ischemic zone diastolic wall thick-
ness from preocclusion control values are shown in Figure
7. No significant changes were observed in nonischemic
zones.
Electrocardiographic data. All dogs exhibited ST seg-
ment elevation after the coronary occlusion. The mean max-
imal ST segment elevation between 0 and 30 minutes of
occlusion observed in a precordial lead equivalent to lead
V4 was 3.8 ± 0.8 mV in group A and 4.3 ± 1.9 mV in
group B. During the early phase of reperfusion (within 60
minutes), all dogs in group A presented with ventricular
30 • Group A
mI Group B
*50 T'SD
*
40 *
*
30 * *~ *
~ 20
~
10
0
-10
-20
PRE c...30' 90' 180'] c...15' 60' 24Hrs 72Hrs 7dOY~
OCCLUSION TIME LAD OCCLUSION TIME CORONARY REPERFUSION
Figure 5. Ischemic zone systolic wall thickening (WT)
at the midpapillary muscles level measured by two-di-
mensional echocardiography 10 control dogs with 3 hours
of untreated left anterior descending (LAD) coronary ar-
tery occlusion and 7 days of reperfusion (group A) and
in dogs treated with hypothermic synchronized retroper-
fusion (group B). Note restoration of wall thickening to
physiologic levels 10 group B when hypotherrruc retro-
perfusion was instituted (after 30 mmutes of coronary
occlusion) and no Improvement 10 wall tluckenmg With
reperfusion 10 group A (SD = standard deviation. *p <
005 relative to group A at equivalent tune points).
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Figure 6. Two-dimen sional echocardiograph-
ic short-axis cross-sec tional views of the LY
at the level of the midpapillary muscles at end-
diastole in an untreated control dog (dog A-5).
Arrows indicate the endocardial and epicardial
surfaces in the ischemic area. A, Normal end-
diastol ic wall thickness in control and B, in
the ischemic region at 180 minutes of left an-
terior descend ing coronary artery occlusion be-
fore reperfusion: C , Marked increase in dia-
stolic wall thickness noted 15 m inutes after
reperfusion in an equivalent short-axis cross
section, and D, Seven days after rcperfusion ,
with increased diastolic wall thickness still
present in the ischemic region . Such a distinct
early reperfusion increase in diastolic wall
thickness was observed in most of the untreated
control dogs (group A). A =anterior; L =lateral;
P =posterior wall and S =septal.
A
c
B
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tachycardia; it appeared in only 4 of the 10 dogs in group
B. Except for one instance, all dogs from group A exhibited
Q waves, and 6 of 9 also developed QS complexes within
I hour of reperfusion. In group B, Q waves appeared in 3
of the 10dogs and QS complexes were present in 2 of 10dogs.
Metabolism. Myocard ial lactate balance measurements
are illustrated in Figure 8. No significant difference between
the groups was noted during the preocclu sion control period
and 30 minutes after occlusion. However, at 90 and 180
minutes after coronary occlusion, lactate balance improved
in group B as compared with persistent lactate production
throughout the period of coronary artery occlusion in group
A. Early after reperfu sion, some lactate extraction is seen
in group A, in contrast with persisting regional left ven-
tricular dysfunction in the ischemic zone (see Fig. 5) .
Temperature measurements. Rectal temperature in
Table 4. Two-Dimensional Echocardiographic Systolic Wall Thickening in Left Ventricular Short-Axis Cross Sections
Time After Coronary Occlusion Time After Coronary Reperfusion
MY level
Group A
Group B
MP level
Group A
Group B
LLY level
Group A
Group B
MP level-I zone
Group A
Group B
MP level-NI zone
Group A
Group B
Control
(preocclusion)
23 ::t 5
21 ::t 7
27 ::t 6
31 ::t 6
40::t 14
36 ::t 8
39 ::t 14
38 ::t 13
37 ::t 7
37 ::t 8
30 min
30 ::t 8
23 ::t 7
14 ::t 5
15 ::t 3
14 ::t 8
12 ::t 6
- 2 ::t II
2 ::t 7
29 ::t 12
21 ::t 5
90 min
29 ::t 7
3 1 ::t 10
15 :!: 6
*26 :t 7
13 :!: 5
*20 :!: 6
I :!: 7
*16 ::t II
25 :!: II
*38 ± 7
180 min
25 ::t 7
29 ::t 8
13 :!: 4
t23 :!: 5
14 ± 5
18 :!: 5
- 0.4 :!: 6
*17 :t 16
24 :!: 10
35 :!: 14
15 min
21 ::t 8
2 1 ::t 8
8 ::t 5
t 20 ::t 5
2 ::t 7
*10 ::t 6
-5 :!: 7
*7 :t 14
26 :t 9
32 :t 14
60 min
18 :!: 3
*23 :t 7
6 ± 8
*21 :!: 7
2 ::t 7
*14 ::t II
- 8 :t 8
*11 ::t 17
27 :t I I
33 :t 17
24 hr
21 :t 8
21 :t 8
8 ± 8
*23 :!: 13
1 :t 6
*22 :t 16
- 7 :t 9
*2 1 ::t 22
22 :t 15
32 :t 13
72 hr
19 :t 3
22 ± 6
II :!: II
*24 :t 7
5 ::t 4
*17 :t 12
- 3 :t 12
*19 ::t 20
27 :t 13
32 :t 17
7 days
18 :t 3
*23 :t 7
12 ± II
*26 :t 8
9 :t 8
*24 :t 10
- 2 :t 17
*25 ::t 24
30 ::t 15
38 ::t 17
*p < 0.05 relative to group A; tp < 0.001 relative to group A.
Values are mean ± standard deviation. I = Ischemic; Ll.V = low left ventricular; MP = rmdpapillary; MY = mural valve. NI = nonischermc.
1074 J AM COLL CARDIOL
1983,1(4) 1067-80
HAENDCHEN ET AL
Table 5. Two-Dimensional Echocardiographic End-Diastolic Wall Thickness (mm) in Left Ventricular
Short-Axis Cross Sections
Time After Coronary Occlusion TIme After Coronary Reperfusion
Control
(preocclusion) 30 nun 90 rrun 180 min 15 min 60 min 24 h 72h 7 days
7.3 ±.7 7.7 ±.6 82 ±
8.1 ±.9 9.2 ± I 9.3 ±
8.5 ± 0.6 8 2 ±.5 8.5 ± 0.8
8.9 ± I 9.0 ± I 93 ± I
7.5 ± 0.6 7.6 ± 0.4 7.5 ± 0.5
8.0 ± 0.7 8.3 ± I 8.6 ± I
8.6 ± 0.7 8.3 ± 8 8.8 ± 0.8
9.2 ± I 9.3 ± I 9 3 ± I
9.0 ± 08
92 ± I
9.1 ±
96 ±
9.5 ± 2
8.4 ± 0.9
10.0 ± 1
92 ± 9
11.2 ± 2
*8.8 ± 1
9.5 ±
9.5 ±
9.5 ± 1
9.6 ± 2
10.3 ±
9.6 ±
102 ±
89 ±
12.0 ± 2
*96 ± I
9.5 ± 2
9.8 ± 2
104 ± 2
98 ± 1
10.4 ± 2
*9.0 ± I
10.2 ± 2
9.8 ± 2
12.1 ± 14
no 1 ± I
9.1 ± 09
9.5 ± I
9.1 ± 1
9.6 ± 2
100 ±
94 ±
10.5 ± 1
*8.9 ± 07
12.6 ± 2
*10 3 ~ 1
9.5 ± 07
97 ± 1
8.7 ± 0 I
94 ± 1
10 0 ± 0.9
95 ± 0.9
10.1 ± 1
*9.0 ± 0.8
12.2 ± 2
*10.0 ± I
8.7 ±
9.6 ±
8.7 ±
98 ±
8.6 ±
9.7 ±
7.6 ± 0.7
8.3 ± I
8.6 ± 0.9
9.1 ± I
9.1 ± 0.9
9.7 ± I
8.4 ± .7
9.2 ± I
8.9 ± 0.9
9.2 ± I
MV level
Group A
Group B
MP level
Group A
Group B
LLV level
Group A
Group B
MP level-I zone
Group A
Group B
MP level-NI zone
Group A
Group B
*p < 0.05 relative to group A, tp < 0.001 relative to group A
Values are mean:': standard devianon I = ischermc, LLV = low left ventncular. MP = rrudpapillary. MV = mitral valve, NI = nomschermc
Figure 7. Percent change In ischemic zone end-diastolic wall thickness
from preocclusion control values (6WTd) , measured by two-dimensional
echocardiography at the midpapillary muscle level. Diastolic wall thickness
decreased by approximately 15% in both groups at 30 minutes of left
antenor descending coronary occlusion. No significant differences in di-
astolic wall thickness were observed between dogs in group A (untreated
3 hours of left anterior descending coronary artery occlusion followed by
7 days of reperfusion) and group B (hypothermic synchronized retroper-
fusion treatment from 30 to 180 minutes of the occlusion period, followed
by 7 days of reperfusion) during the occlusion penod. However, early
after reperfusion. dogs In group A exhibited marked increase In diastolic
wall thickness which persisted throughout the 7 day period, as opposed to
dogs In group B in which only minor changes were observed after reper-
fusion (*p < 0.01, **p < 0.001 relative to group B). Abbreviations as
In Figure 5
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group A decreased nonsignificantly from 36.9 ± 0.8°e in
the control period to 36.3 ± l.O'C at 3 hours after coronary
occlusion. In group B, rectal temperatures decreased from
36,7 ± 0,6°e in the control period to 35.0 ± 1.39°e at 3
hours of occlusion (p < 0,05),
Pathologic findings. Infarct size. The results of infarct
size measurements, expressed as percent of the left ventricle
(including interventricular septal mass), are listed in Table
6. Infarct size was significantly lower in the hypothermic
retroperfusion group (group B). In group A, 6 of 9 dogs
exhibited large hemorrhagic myocardial infarctions (12% or
more of the left ventricle). Although one dog in that group
had a transmural infarction, the others presented with nearly
transmural infarction, with a subepicardial layer free of ne-
crosis (Fig, 9A). In group B, the most common finding after
sacrificing the animals was that necrosis was limited to the
subendocardial layer and was usually of a small focal char-
acter (Fig. 9B), although in some cases damage was more
extensive (dogs B-6 and B-8). One of the dogs in this group
(dog B-8) had a large area of necrosis, comparable with that
of the majority of the dogs in group A.
Coronary sinus and coronary venous damage. Necropsy
examination on the 7th day indicated no significant damage
to the coronary venous system in any of the dogs in group
B. One dog exhibited a small area of hemorrhage in the fat
tissue at gross examination; slight hemorrhage of the right
atrial myocardium with a minute thrombus in the great car-
diac vein was recognizable only by microscopic examina-
tion. A second dog had a nonsignificant endothelial venous
abnormality, commonly seen in most vascular catheterizations.
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Figure 8. Myocardial lactate balance in untreated control dogs
(group A) and m dogs pretreated with hypothermic retroperfusion
(group B). At 30 mmutes coronary occlusion, lactate balance
dropped to nearly zero in both groups. Note the improvement in
lactate balance at 90 and 180 nunutes of the coronary occlusion
when hypothermic retroperfusion was applied (starting at 30 nun-
utes coronary occlusion), whereas lactate production persists
throughout the period of coronary occlusion in the untreated group
A. Values are means (M) ± standard error of mean (SEM). *p
> 0 05 relativeto group A Ao =aorta; GCV =great cardiac vein;
Pre = preocclusion.
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Discussion
Pretreatment of reperfusion by hypothermic retro-
perfusion. This study suggests that moderately hypo-
thermic synchronized retroperfusion, applied after acute
coronary occlusion and before reperfusion, provides signif-
icant improvement in function and extends viability of isch-
emic myocardium. The latter was verified by measuring
infarct size after 7 days of reperfusion. Whereas 6 of 9
control dogs exhibited significant and persistent derange-
ments of left ventricular function, with marked arrhythmias
after reperfusion and larger infarct size on the 7th day, 7
of 10 dogs undergoing retroperfusion demonstrated small
infarcts, manifested improved function and a lesser degree
of electrocardiographic abnormalities after reperfusion. Over
the 7 day reperfusion period, mortality was 2 (16.6%) of
12 dogs in group B versus 4 (30.7%) of 13 dogs in group
A. We presume that the effectiveness of the hypothermic
Table 6. Infarct Size in Dogs With Coronary Occlusion and Reperfusion (group A) and With Hypotherrmc Retroperfusion
Pretreatment (group B)
Dog LV Mass (g) NecrotiC Mass (g) % of LV Necrosis
Group A (control group)
A-I
A-2
A-3
A-4
A-5
A-6
A-7
A-8
A-9
Mean
SD
B-1
B-2
B-3
B-4
B-5
B-6
B-7
B-8
B-9
B-IO
Mean
SD
130.5
160.6
102.6
97.4
135.6
122.0
1164
948
129.2
121.0
± 21.0
169.5
163.1
148.3
139.0
142.0
109.8
96.1
100.8
131.8
91.4
129.1
±282
15.6
20.1
135
22.2
22.0
6.0
3.6
63
240
14.8
±7.9
Group B (hypothermic retroperfusion group)
0.85
2.3
0.8
2.2
o
11.9
8.28
17.3
2.13
034
t46
±5.9
12.0
12.5
13.2
228
16.2
5.0
3.1
6.7
18.6
12.2
±6.5
05
14
05
07
o
110
8.6
17.1
I 6
0.4
*4.2
±5.9
*p < 0.02 relative to Group A. tp < 0 01 relative to Group A
LV = left ventricular, SD = standard devianon
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Figure 9. Transverse slices of the left ventricle at the papillary muscle
level stained with triphenyl-tetrazolium-chloride (TIC). A, A dog with 3
hours of untreated left anterior descending coronary artery occlusion and
7 days of reperfusion (group A, dog A-2). The agent stains normal myo-
cardium in red, and does not stain the necrotic area, which in this case
was hemorrhagic and relatively large, although the subepicardiallayer was
spared. B, A dog treated with hypothermic retroperfusion between 30 and
180 mmutes of the occlusion penod (dog 8-9), showing focal necrosis
limited to the subendocardium (arrows). The necrotic mass in dog A was
20.1 g, while in dog B it was only 2.13 g. Anatomic slices are oriented
accordingly to echocardiographic cross sections. Regional wall motion
analysis m equivalent two-dimensional echocardiographic short-axis cross
sections in dogs A and 8 are shown in Figure 10. RV = right ventricle.
Other abbreviations as in Figure 5.
retroperfusion treatment is due to retrograde delivery of
arterial blood to the acutely ischemic myocardium, as well
as a significant reduction in myocardial oxygen demand.
The lack of improvement in segmental wall motion and wall
thickening observed after reperfusion in most of the control
dogs, as well as relatively large myocardial infarcts, con-
firms that coronary occlusions for periods as short as 3 hours
can be associated with significant irreversible myocardial
damage. Our observation of increased diastolic wall thick-
ness in the ischemic region of control dogs suggests that
severe myocardial edema or impaired myocardial relaxation
may occur with sudden reperfusion after 3 hours of coronary
occlusion, resulting in more severe and prolonged compro-
mising of myocardial function.
Treatment of acute myocardial ischemia and reper-
fusion. A variety of medical treatments of acute myocardial
ischemia and reperfusion-induced derangements have been
proposed and investigated (22), Most of these methods are
aimed at either reducing myocardial oxygen demands or
increasing myocardial oxygen supply, primarily by way of
collateral vessels. Additional pharmacologic management
is designed to provide direct myocardial effects and treat
the cellular defects incurred by the acute ischemic injury.
Conclusions derived from some of the intervention studies
are difficult to evaluate or compare because the treatments
were applied at differing periods, either before or after re-
perfusion. Differences in experimental preparation may also
contribute to discrepancies in reported results.
It is not surprising that particular attention has been paid
to pharmacologic agents which might counteract the pre-
sumed mechanisms that lead to the so-called "no reflow
phenomenon." Among these mechanisms are I) cell swell-
ing and myocardial edema, leading to extravascular con-
striction of microcirculatory vessels that supply blood to the
already underperfused ischemic region; 2) capillary damage;
and 3) calcium overloading of the mitochondria, resulting
in failure of myocardial contraction and inability of cardiac
fibers to relax. Administration of hyperosmolar mannitol
has been proposed and used in the experimental setting,
because of its potential ability to reduce cell swelling and
interstitial edema (2). Corticosteroids have also been re-
ported to have beneficial effects on the no reflow phenom-
enon (3). More recently, calcium antagonists have been used
to counteract the latter mechanism (6-8).
The potential benefit of reperfusion after acute coronary
occlusion is a controversial issue. Although it appears cer-
tain that such benefit can be achieved, it is also inversely
related to the duration of the coronary occlusion preceding
reperfusion. Several investigators (23-26) have demon-
strated in conscious and anesthetized animals that statisti-
cally significant improvements in myocardial metabolism
and function, a reduction in infarct size and improved sur-
vival, may be achieved if reperfusion is established within
3 hours after an acute coronary occlusion. However, re-
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Figure 10. Two-dimensional echocardiographic computer-
assisted segmental wall motion analysis of endocardial out-
lines. Left ventricular endocardium at the rnidpapillary muscle
level IS indicat ed with continuous lines at end-diastole and
with dashed lines at end-systole (stippled area). Systolic
fractional area change (FAC) was calculated for the entire
cross section as well as for individual segments as indicated.
Left panel , Untreated dog from group A (dog A-2) showing
reduced sectional fractional area change of 3 1.0% at 30 min-
utes of coronary occlusion (normal values during the preoc-
elusion state, see Table 3), as well as severe regional dys-
function in segments I and 2 (antero-lateral region); at 180
minutes of left anterior descending (LAD) coronary artery
occlusion there was further deterioration in sectional as well
as in regional contraction abnormalities. and dysfunction per-
sisted to the 7th day of reperfusion. Right panel, Dog pre-
treated with hypothermic retroperfusion (between 30 and 180
minutes of the coronary occlusion) showing reduced sectional
and regional fractional area change at 30 minutes of occlusion.
At 180 minutes of occlusion (150 minutes H-SRP), there was
a significant improvement in sectional fractional area change
as well as segmental wall motion with near normal regional
and global function on the 7th day of rcperfusion. EDA= end-
diastolic area; ESA=end-systolic area, ' =end-diastolic geo-
metric center; *= end-systolic geometric center. Other ab-
breviations as in Figure 5.
GROUP A GROUP B (H -SRP)
perfusion was often associated with a temporary but poten-
tially serious deterioration in cardiac function. Bush et al.
(27) recently reported that it takes several weeks for myo-
cardial function to improve after reperfu sion following 2
hours of coronary occlusion in conscious dogs. This delayed
return of function found even in moderately dysfunctional
region s after coronary occlusion is probably related not only
to metabolic factors, but maybe also to prolonged myo-
cardi al edema, as suggested in the present study by increased
diastolic wall thickness persisting in the ischemic zone, even
Iweek after reperfusion (see Table 5 for details). However,
segmental function in regions with more severe dysfun ction
did not return to physiologically important levels 4 weeks
after reperfusion in their study. Similar findings were pre-
viously reported by Theroux et al. (26).
Myocardial hemorrhage associated with reperfusion is
also belie ved to be related to the duration of coronary oc-
clusion (28.2 9). Recentl y, Higginson et al. (30) reported
that the extent of hemorrhage after reperfusion was inversely
related to myocardial creatine kinase and collateral flow,
and concluded that reperfusion hemorrhage occurs only into
myocardium already markedly compromised at the time of
reperfusion .
Surgical reperfusion . In spite of the beneficial effects
observed in the experimental setting, several interventions
have not yet been proved satisfactory in patients with a large
evolving myocardial infarction (3 1). This led many inves-
tigators to believe that a radical reduction in myocardial
infarct size after acute coronary occlusion can be achieved
only by early restorati on of blood flow in the compromised
coronary artery . Thus, clinical trials reported by Berg et al.
(32) indicated that coronary artery bypass surgery in the
early phase of acute myocardi al infarction was associated
with a low mortality . In a more recent study, DeWood et
al. (33) suggested that " If the result of surgical reperfusion
as a treatment for acute evolvin g myocardial infarct ion is
to be significantl y better than conventional medical man-
agement, revascularization must be performed earl y in the
course of myocardial infarction ." Another recent study by
Phillips et al . (34) suggests that " Emergency coronary artery
revascularization in patients with acute evolving myocardial
infarction is warranted." However, much controversy still
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exists as to the benefits of emergency revascularization in
patients with acute myocardial infarction (35,36). In the last
2 years, a new approach was introduced in the form of
nonsurgical thrombolytic reperfusion, which has now been
applied in patients with evolving myocardial infarction (37-
40).
Limitations of standard reperfusion methods after coro-
nary occlusion. One of the major limitations of surgical or
nonsurgical reperfusion in patients with acute myocardial
infarction is the time delay from the acute coronary occlu-
sion to achievement of adequate restoration of flow. The
time to restoration of normal cardiac function may be further
extended in view of the no reflow phenomenon, which ap-
parently depends on the severity of the ischemic injury and
extent of compromised myocardium. Intracoronary throm-
bolytic procedures, as well as emergency coronary artery
bypass surgery, are subject to logistic limitations because
they require not only a complete and experienced surgical
team on duty, but also a catheterization laboratory, its staff
and the cardiologists. Unless these teams are immediately
ready for the procedure, it may be difficult to institute re-
perfusion before myocardium is already severely compro-
mised, in which case benefits of flow restoration might be
questionable or even deleterious (2). Hence, a temporary
intervention and circulatory assistance is needed to at least
delay any irreversible myocardial damage and maintain car-
diac function until definitive anterograde surgical or non-
surgical reperfusion can be instituted. The more gradual
process of retrograde arterial blood restoration to an acutely
ischemic area during synchronized retroperfusion may ex-
plain the lesser derangements in cardiac function compared
with those observed during a sudden anterograde coronary
artery reperfusion (41). We have not seen a "retroperfusion
no reflow phenomenon," but rather prompt improvement
in cardiac function when retroperfusion was used after ex-
perimental coronary occlusion. Thus, hypothermic syn-
chronized retroperfusion of the coronary veins could be an
alternative intervention in patients with acute myocardial
infarction.
Does retroperfusion really perfuse the ischemic myo-
cardium? Berdeaux et al. (16), using a radioactive rni-
crosphere technique, demonstrated that diastolic synchro-
nized retroperfusion does reach and provide perfusion to the
ischemic (as well as nonischemic) zones of the left ven-
tricular wall, while favorably redistributing blood flow within
the ischemic zone toward the endocardium. We have also
demonstrated, by means of carbon colloidal particles of
approximately 600 A injected through the retroperfusion
system, that the arterial blood retroperfusate reaches the
ischemic zone (1).
Is synchronized retroperfusion a safe procedure? Mi-
croscopic examination of the hearts from the 10 treated dogs
in group B did not show any significant damage to the
coronary sinus or veins, nor intramyocardial damage from
our retroperfusion balloon catheter. In a parallel safety study
conducted in our laboratory in 20 dogs with 3 hours of
synchronized retroperfusion, detailed hematologic and path-
ologic examinations were performed to assess any damage
to red and white blood cells, platelets or cardiac tissue. No
significant alterations in any of these variables were noted
in the study, except for one dog in which an occlusive great
cardiac vein thrombus, endothelial damage and myocardial
hemorrhage were found. Damage induced during great car-
diac vein catheterization could not be ruled out in this case.
Thus, we believe that synchronized retroperfusion is a safe
procedure and no significant damage should be encountered,
provided that a careful catheterization and appropriate re-
troperfusion catheters and flows are employed.
Practical implications. Retroperfusion of the coronary
veins is a relatively simple technique. Catheterization of the
coronary sinus and great cardiac vein can be easily and
quickly performed under fluoroscopy in the emergency room.
Counterpulsation units are available, and satisfactory prog-
ress is being made to produce professionally manufactured
retroperfusion catheters. A distinct advantage of the retro-
perfusion method is that one can deliver moderate hypo-
thermia in a retrograde fashion, as well as pharmacologic
agents, to further enhance salvage of the acutely ischemic
myocardium (42-44). In a previous report, we (11) dem-
onstrated that hypothermic retroperfusion can improve func-
tion and extend myocardial viability not only for 3 hours
but up to 6 hours of maintained left anterior descending
coronary artery occlusion. In the same study, we compared
the effects of normothermic and hypothermic retroperfusion
and found significantly better results in terms of cardiac
function and infarct size when hypothermia was combined
with retroperfusion of arterial blood.
Limitations of the method. One of the limitations of
the current method is that retroperfusion has not been applied
in right coronary and left circumflex coronary artery occlu-
sions. The efficiency of retrograde delivery of arterialized
blood to specific regions of the myocardium depends on
pressure, flow and the extent of coronary veno-venous
shunting. These shunts can actually be beneficial and min-
imize a potential buildup of coronary intravenous pressures
that might be encountered with excessive retroperfusion flows
or inadequate coronary venous drainage. We have found
from previous experience that pressures up to 50 mm Hg
within the anterior interventricular vein as well as retrograde
flows up to 80 cc/min are not associated with heart damage
(18).
Moderate hypothermia delivered with our great cardiac
vein retroperfusion system could extend its benefits through
cooling a larger portion of the left or even right ventricle,
via coronary venous shunts, thus also benefiting myocardial
regions distal to an occluded circumflex or right coronary
artery. Limited data from this laboratory obtained recently
in open chest dogs with comprehensive mapping of myo-
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cardial temperatures indicate that the drop in myocardial
temperature is rapid, moderate and relatively uniform along
the ventricles, with very small temperature gradients (un-
published data). More studies are needed to evaluate the
role of retrograde delivery of hypothermia during right and
circumflex coronary artery occlusions.
Conclusions. Hypothermic synchronized retroperfusion
was applied in a group of closed chest dogs as a treatment
of acute myocardial ischemia, before anterograde coronary
reperfusion, and results were compared with those in a group
of equivalent control dogs with untreated coronary occlusion
and reperfusion. A significant reduction in infarct size was
observed in dogs with the retroperfusion treatment, and
these treated dogs also presented less derangement in cardiac
function during the critical no reflow period. We conclude
that moderate hypothermic synchronized retroperfusion can
be effectively used to protect acutely ischemic myocardium
and delay the otherwise rapidly progressing irreversible
myocardial ischemic injury. Such hypothermic retroperfu-
sion treatment might be applied during the earliest period
after an acute myocardial infarction, pending permanent
reestablishment of coronary flow by means of current sur-
gical or nonsurgical reperfusion procedures.
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